Prof David Yeung (BSc (Med), MBBS (Hons), FRACP, FRCPA, PhD) is the head of haematology at the Royal Adelaide Hospital; Clinical Associate Professor at the Adelaide Medical School; and SA Cancer Council Beat Cancer Project Clinical Investigator at the South Australia Health and Medical Research Institute. David received his haematology and BMT training in Sydney, before completing his PhD studies in Adelaide on the optimal use of tyrosine kinase inhibitors (TKI) as targeted therapy for chronic myeloid leukaemia (CML). David’s clinical research portfolio as principal investigator include several frontline TKI studies conducted through the Australasian Leukaemia and Lymphoma Group. He is a board director of Australia and New Zealand Transplant and Cellular Therapies.